Luke Mountjoy
Impact in
-
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Oncology 7
- CAR-T cell therapy research 3
- Colorectal Cancer Treatments and Studies 1
- Cancer Treatment and Pharmacology 1
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Diana Almader‐Douglas (1 shared paper)Joleen M. Hubbard (1 shared paper)Tanios Bekaii‐Saab (1 shared paper)Kabir Mody (1 shared paper)Daniel H. Ahn (1 shared paper)M. Hassan Murad (1 shared paper)Mohamad Bassam Sonbol (1 shared paper)Belal Firwana (1 shared paper)
- Journals
- Blood (5 papers)Current Oncology Reports (1 paper)New England Journal of Medicine (1 paper)Transplantation and Cellular Therapy (1 paper)Blood Cancer Journal (1 paper)
- Partner nations
- United States
In The Last Decade
Luke Mountjoy
14 papers receiving 146 citations
Peers
Comparison fields: 5 of 39
- Oncology 86
- Hematology 32
- Transplantation 5
- Genetics 14
- Hepatology 9
Countries citing papers authored by Luke Mountjoy
This map shows the geographic impact of Luke Mountjoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Mountjoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Mountjoy more than expected).
Fields of papers citing papers by Luke Mountjoy
This network shows the impact of papers produced by Luke Mountjoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Mountjoy. The network helps show where Luke Mountjoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Mountjoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 69 | |
| 2 | 2023 | 17 | |
| 3 | 2017 | 14 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 7 | |
| 6 | 2020 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2017 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2019 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2021 | 0 | |
| 16 | 2018 | 0 |
About Luke Mountjoy
Luke Mountjoy is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 16 papers that have together received 148 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Genomics and Diagnostics (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (86 citations), Hematology (32 citations), Transplantation (5 citations), Genetics (14 citations) and Hepatology (9 citations). Luke Mountjoy has collaborated with scholars based in United States. Frequent co-authors include Diana Almader‐Douglas, Joleen M. Hubbard, Tanios Bekaii‐Saab, Kabir Mody, Daniel H. Ahn, M. Hassan Murad, Mohamad Bassam Sonbol, Belal Firwana, Mitesh J. Borad and Geoffrey C. Wall. Their work appears in journals such as Blood, Current Oncology Reports, New England Journal of Medicine, Transplantation and Cellular Therapy and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.